Skip to content
GLP-1 Decoder

Rybelsus for Teens: Evidence, Eligibility, Coverage

No. Rybelsus is not approved for anyone under 18. It is approved for adults only: type 2 diabetes and heart risk. In STEP TEENS, BMI fell 16.1% on average for people on Wegovy, vs 0.6% on placebo.

For teens
Adults only
Active ingredient
semaglutide
How it is taken
daily tablet
Best result (STEP TEENS)
16.1% drop in BMI

Rybelsus: quick facts

How long the drug remains in the body
100%50%25%0%07 d14 d21 d28 d35 d50%25%12.5%time after the dose

Its half-life is about 1 week. After 7 d, half is gone, and after five half-lives (35 d), about 3% remains.

Main trial weight loss
Rybelsus (PIONEER 1)3.7 kgPlacebo1.4 kg

In PIONEER 1, people with type 2 diabetes lost 3.7 kg over 26 weeks, while those on placebo lost 1.4 kg.

How the price changes over time
20262027$1,027.51$0List priceSelf-pay

The maker's price page lists monthly price points in US dollars for the list price and self-pay offers.

Sources: FDA label (DailyMed), healthsystemtracker.org, Novo Nordisk pricing, Novo Nordisk.

Who qualifies?

Rybelsus: who qualifies
SourceWho qualifies
FDA labelFor adults with type 2 diabetes, this medicine lowers blood sugar when used with diet and exercise.
FDA labelFor high-risk adults with type 2 diabetes, it lowers the risk of heart attack, stroke, or heart-related death.

Sources: FDA label (DailyMed).

Trial results for teens

No trial of Rybelsus itself is part of this group. The trials here study other brands that use the same ingredient.

Trials using semaglutide, the same ingredient
TrialMedicineWho took partLengthPeopleMain resultComparison
STEP TEENS WegovyTeens aged 12 to 17 with obesity68 weeks20116.1% drop in BMI0.6% on placebo

Source of the study: STEP TEENS (PubMed).

What is different for teens?

Teen label points for Rybelsus
What changesWhat the label says
Acute PancreatitisCan cause inflammation of the pancreas. Get care and stop taking it when severe stomach pain continues.
Acute Gallbladder DiseaseGallstones and gallbladder inflammation can happen. A fever, yellow skin or eyes, or upper-right belly pain should be reported.

The FDA label (DailyMed) provides the label information.

Warnings in the label come from the FDA label at DailyMed.

Coverage for teens

Alternatives for teens

GLP-1 medicines and teens
MedicineFor teensHow it is takenTrial result
WegovyFrom age 12, for weight lossweekly injection or daily tablet16.1% drop in BMI
MounjaroFrom age 10, for type 2 diabetesweekly injectionNot listed
TrulicityFrom age 10, for type 2 diabetesweekly injectionNot listed
SaxendaFrom age 12, for weight lossdaily injectionNot listed
VictozaFrom age 10, for type 2 diabetesdaily injectionNot listed
RybelsusAdults onlydaily tabletNot listed
OzempicAdults onlyweekly injectionNot listed
ZepboundAdults onlyweekly injectionNot listed
FoundayoAdults onlydaily tabletNot listed
ByettaAdults onlytwice-daily injectionNot listed

References: FDA label at DailyMed, PubMed.

Questions to ask your prescriber

Read the full Rybelsus prescribing information on DailyMed.